Skip to main content
. 2022 Aug 5;11(1):1950–1958. doi: 10.1080/22221751.2022.2103455

Table 3.

Factors associated with Delta and Omicron variant pneumonia.

Variable   Delta variant       Omicron variant
Pneumonia OR p value Adjusted OR p value Pneumonia OR p value Adjusted OR p value
N (%) (95% CI) (95% CI) N (%) (95% CI) (95% CI)
Gender                    
Female 122(52.1) Ref   Ref   44(18.4) Ref   Ref  
Male 76(44.4) 0.73 (0.49–1.09) 0.127 0.72 (0.46–1.13) 0.153 36(19.8) 1.09 (0.67–1.78) 0.723 1.27 (0.76–2.14) 0.359
Age Group (years)                    
<18 4(6.7) Ref   Ref   26(13.4) Ref   Ref  
18–49 79(45.1) 11.52 (4.00–33.15) <0.0001 10.16(3.39–30.43) <0.0001 33(19.2) 1.53 (0.88–2.69) 0.135 0.99 (0.5–1.89) 0.963
≥50 115(67.7) 29.27 (10.10–84.80) <0.0001 25.70(8.56–77.10) <0.0001 21(38.2) 3.99 (2.02–7.90) <0.0001 1.45 (0.56–3.63) 0.433
Comorbidities                    
No 163(46.3) Ref   Ref   65(16.7) Ref   Ref  
Yes 35(66.0) 2.25 (1.23–4.13) 0.001 1.33 (0.67–2.65) 0.423 15(46.9) 4.40 (2.09–9.25) <0.0001 2.95 (1.16–7.63) 0.024
Vaccination Status                    
Full primary ≥180 days 83(69.2) Ref   Ref   29(36.7) Ref   Ref  
Full primary <180 days 95(43.2) 0.34 (0.21–0.54) <0.0001 0.48 (0.28–0.81) 0.006 49(14.8) 0.30 (0.17–0.52) <0.0001 0.34 (0.17–0.67) 0.002
Booster dose 20(30.8) 0.20 (0.10–0.38) <0.0001 0.18 (0.09–0.35) <0.0001 2(20.0)  –  –  –  

Note: *Indicates that the number of cases is too small to make a valid estimate.